Thrombopoietin (TPO) is a recently identified growth factor that regul
ates megakaryocytopoiesis. Its receptor, c-Mpl, is expressed in megaka
ryocyte progenitors, mature megakaryoytes, and human blood platelets.
We have observed that TPO treatment of human platelets resulted in tyr
osine phosphorylation of several cellular proteins, including the c-Mp
l receptor and the 85-kD subunit of phosphatidylinositol 3-kinase (PI
3-K). TPO stimulated this tyrosine phosphorylation in a time-dependent
manner, reaching a maximum in 5 minutes. The tyrosine phosphorylation
of PI 3-K was dependent on the concentration of TPO and reached a max
imum at concentrations between 50 and 100 ng/mL. This phosphorylation
was independent of extracellular fibrinogen and ligation of the alpha(
IIb)beta(3) integrin. In contrast, TPO, in the presence of exogenous f
ibrinogen, induced concentration-dependent platelet aggregation, which
was blocked by the soluble c-Mpl receptor. Increasing TPO concentrati
ons modulated the degree of the primary wave of aggregation and the la
g phase, but not the slope or maximum of the secondary wave of aggrega
tion. This secondary aggregation was controlled by the addition of apy
rase, suggesting an adenosine diphosphate (ADP)-dependent mechanism. T
reatment of platelets with TPO resulted in augmented binding of I-125-
fibrinogen to intact platelets, with a 50% effect (EC(50)) occurring b
etween 5 and 10 ng/mL. TPO-induced binding of fibrinogen to platelets
was comparable in degree with that observed by stimulation with 10 mu
mol/L ADP. In an immobilized collagen-platelet adhesion assay, a signi
ficant increase in the attachment of TPO-stimulated platelets was obse
rved. This effect was dependent on the concentration of TPO. At 50 ng/
mL of TPO, platelet attachment to collagen increased threefold compare
d with the buffer control. Furthermore, the presence of fibrinogen did
not significantly alter TPO augmentation of the platelet-collagen int
eraction. This interaction was mediated by the Arg-Gly-Asp (RGD) adhes
ion recognition sequence, as it was completely abolished by 100 mu mol
/L of the RGDS peptide. A fraction of the TPO-dependent platelet attac
hment to a collagen-coated surface was insensitive to treatment with p
rostaglandin E(1). Furthermore, antibody to alpha(IIb) integrin partia
lly inhibited platelet attachment to collagen, suggesting that the int
egrin alpha(IIb)beta(3) participates in this association. These data i
ndicate that TPO might function not only as a cytokine in megakaryocyt
e growth and differentiation, but may also participate in direct plate
let activation and modulate platelet-extracellular matrix interactions
. (C) 1995 by The American Society of Hematology.